A Delphi consensus for implementing genomic testing in unresectable or metastatic urothelial cancer.

Hussain SA, Challapalli A, Gill S, Hubank M, Markham H, Tanière P, Wyatt S, Jones R

Open source

DOI
10.1111/bju.70278
Published
2026 Jul
Container
BJU international
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bju.70278,
  title = {A Delphi consensus for implementing genomic testing in unresectable or metastatic urothelial cancer.},
  author = {Hussain SA and Challapalli A and Gill S and Hubank M and Markham H and Tanière P and Wyatt S and Jones R},
  year = {2026},
  journal = {BJU international},
  doi = {10.1111/bju.70278},
  url = {https://doi.org/10.1111/bju.70278}
}

RIS

TY  - JOUR
TI  - A Delphi consensus for implementing genomic testing in unresectable or metastatic urothelial cancer.
AU  - Hussain SA
AU  - Challapalli A
AU  - Gill S
AU  - Hubank M
AU  - Markham H
AU  - Tanière P
AU  - Wyatt S
AU  - Jones R
PY  - 2026
JO  - BJU international
DO  - 10.1111/bju.70278
UR  - https://doi.org/10.1111/bju.70278
ER  - 

APA

SA, H., A, C., S, G., M, H., H, M., P, T., S, W., & R, J. (2026). A Delphi consensus for implementing genomic testing in unresectable or metastatic urothelial cancer.. BJU international. https://doi.org/10.1111/bju.70278

Source records